Benzinga | Aug 10, 2020 04:30PM EDT

Soleno Therapeutics Q2 EPS $(0.16) Up From $(0.31) YoY

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.16) per share. This is a 48.39 percent increase over losses of $(0.31) per share from the same period last year.